Israeli biotech Pharmaseed has initiated a new project bringing Israeli, Jordanian and Swiss researchers together to search for a cure for cutaneous leishmaniasis. The parasitic disease is common in the Middle East and can cause death in patients with weak immune systems.
Israel & Jordan work to cure parasitic disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.